69778-83-2, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 69778-83-2, name is 4-Methoxy-1H-pyrrol-2(5H)-one, introducing its new discovery.
TRIHETEROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING CANCER OR VIRAL DISEASES
The present invention relates to novel Triheterocyclic Compounds, formula (I): and pharmaceutically acceptable salts thereof, where in: Q1is -O-, -S- or -N(R1)-; Q2 is -C(R3)- or -N-; Q3is -C (R5)- or -N-; Q4 is -C (R9)- or -N-; compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.69778-83-2, you can also check out more blogs about69778-83-2
Reference£º
Pyrroline – Wikipedia,
1-Pyrroline | C4H7N – PubChem